https://www.globalbiotechinsights.com/tag/195/pharmaceuticals IDTechEx provides independent analysis on the development and application of RFID, Printed Electronics, Photovoltaics and Energy Harvesting en Copyright (C) IDTechEx Ltd Doxorubicin, originally daunorubicin, is the result of a simultaneous discovery event in the 1950's between researchers in France and Italy. The molecule, a well-known anti-cancer drug used for a variety of indications ranging from acute lymphocytic leukemia to breast cancer, was approved for use in the United States in 1974.https://www.idtechex.com/en/research-article/nanoparticles-breathe-new-life-into-doxorubicin-cancer-treatment/11211?rsst2id=195https://www.idtechex.com/en/research-article/nanoparticles-breathe-new-life-into-doxorubicin-cancer-treatment/11211?rsst2id=195Fri, 16 Jun 2017 ZZZalexis@IDTechEx.com (Dr Alexis Karandrea)